Ashley Cordova

Insider Reports History

Location
Baar
Signature
Steven Robbins, as attorney in fact for Cordova, Ashley
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ashley Cordova:

Company Role Class Num Shares Value Price $ Report Date Ownership
NovoCure Ltd Chief Executive Officer Ordinary Shares 437,569 $5,348,799 $12.22 05 Sep 2025 Direct
NovoCure Ltd Chief Executive Officer Stock Options (Right to buy) 224,123 $4,076,797 $18.19 04 Mar 2025 Direct

Insider Reports Filed by Ashley Cordova

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NVCR NovoCure Ltd 05 Sep 2025 1 +$996,859 4 Chief Executive Officer 08 Sep 2025, 07:10
NVCR NovoCure Ltd 30 Jun 2025 1 +$12,603 4 Chief Executive Officer 01 Jul 2025, 16:19
NVCR NovoCure Ltd 04 Mar 2025 2 +$6,826,780 4 Chief Executive Officer 06 Mar 2025, 16:39
NVCR NovoCure Ltd 03 Mar 2025 1 -$38,055 4 Chief Executive Officer 04 Mar 2025, 16:19
NVCR NovoCure Ltd 27 Feb 2025 3 -$266,126 4/A Chief Executive Officer 03 Mar 2025, 21:26
NVCR NovoCure Ltd 31 Dec 2024 1 +$5,501 4 Chief Executive Officer 03 Jan 2025, 16:04
NVCR NovoCure Ltd 02 Aug 2024 1 -$13,857 4 Chief Financial Officer 05 Aug 2024, 16:25
NVCR NovoCure Ltd 28 Jun 2024 1 +$15,741 4 Chief Financial Officer 06 Aug 2024, 16:19
NVCR NovoCure Ltd 27 Feb 2024 2 +$4,215,131 4 Chief Financial Officer 29 Feb 2024, 16:43
NVCR NovoCure Ltd 31 Oct 2023 8 +$172,453 4 Chief Financial Officer 02 Nov 2023, 16:20
NVCR NovoCure Ltd 01 Sep 2023 1 -$19,265 4 Chief Financial Officer 05 Sep 2023, 17:24
NVCR NovoCure Ltd 02 Aug 2023 1 -$34,607 4 Chief Financial Officer 04 Aug 2023, 16:02
NVCR NovoCure Ltd 30 Jun 2023 1 +$12,948 4 Chief Financial Officer 06 Jul 2023, 16:13
NVCR NovoCure Ltd 03 Mar 2023 2 -$419,257 4 Chief Financial Officer 07 Mar 2023, 15:51
NVCR NovoCure Ltd 02 Mar 2023 2 -$79,418 4 Chief Financial Officer 06 Mar 2023, 15:40
NVCR NovoCure Ltd 28 Feb 2023 3 +$2,881,245 4 Chief Financial Officer 02 Mar 2023, 15:55
NVCR NovoCure Ltd 06 Jan 2023 1 +$4,112 4 Chief Financial Officer 10 Jan 2023, 15:18
NVCR NovoCure Ltd 02 Dec 2022 2 $0 4 Chief Financial Officer 05 Dec 2022, 15:33
NVCR NovoCure Ltd 02 Sep 2022 1 -$69,948 4 Chief Financial Officer 06 Sep 2022, 17:15
NVCR NovoCure Ltd 02 Aug 2022 1 +$499,964 4 Chief Financial Officer 03 Aug 2022, 16:45
NVCR NovoCure Ltd 05 Jul 2022 1 +$14,828 4 Chief Financial Officer 07 Jul 2022, 17:49
NVCR NovoCure Ltd 08 Mar 2022 1 -$53,206 4 Chief Financial Officer 09 Mar 2022, 15:51
NVCR NovoCure Ltd 03 Mar 2022 4 $0 4 Chief Financial Officer 11 Mar 2022, 15:55
NVCR NovoCure Ltd 03 Mar 2022 5 +$3,324,830 4 Chief Financial Officer 07 Mar 2022, 17:26
NVCR NovoCure Ltd 06 Jan 2022 1 +$2,936 4 Chief Financial Officer 12 Jan 2022, 16:37
NVCR NovoCure Ltd 02 Nov 2021 1 -$22,421 4 Chief Financial Officer 03 Nov 2021, 16:11
NVCR NovoCure Ltd 02 Sep 2021 1 -$114,456 4 Chief Financial Officer 07 Sep 2021, 16:37
NVCR NovoCure Ltd 12 Aug 2021 18 -$2,696,957 4 Chief Financial Officer 16 Aug 2021, 16:40
NVCR NovoCure Ltd 06 Jul 2021 1 +$13,712 4 Chief Financial Officer 08 Jul 2021, 17:35